Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

A reduction in BMI among adults is associated with lower health care spending, study suggests

A study reveals that weight loss can lead to significant healthcare savings, with 7% savings for a 5% BMI reduction and 30% for a 25% reduction in adults.

6 Dec 2024

Chikungunya's health and economic impact likely underestimated

This study assesses chikungunya's health and economic impacts, revealing significant burdens on health systems and a global cost of approximately $49.9 billion.

5 Dec 2024

Women with infertility have higher risk of developing systemic autoimmune diseases

Women who experience infertility but do not use fertility treatments have a higher risk of developing a group of conditions called systemic autoimmune rheumatic diseases (SARD) in the nine years after a naturally conceived birth compared to women without fertility problems.

4 Dec 2024

Common farming pesticides linked to rheumatoid arthritis

Exposure to specific pesticides is linked to increased rheumatoid arthritis risk, with notable dose-response trends for malathion and carbofuran among older licensed applicators in the Agricultural Health Study.

4 Dec 2024

Nanozyme breakthrough offers new hope for viral pneumonia treatment

A recent study in Nature Materials introduces an inhalable nanozyme treatment for viral pneumonia, showing promising results in reducing inflammation and viral load in various mouse models. The nanozyme, CeTA-K1tkP, demonstrates broad-spectrum effects and biocompatibility, offering a potential new approach to treating pneumonia and other inflammatory conditions.

3 Dec 2024

UTHealth study could set new standards for treating acromioclavicular joint injuries in athletes

A new UTHealth Houston study focused on finding the best surgical technique for reconstruction of the acromioclavicular joint (ACJ), where the collarbone meets the shoulder blade, has the potential to enhance recovery and long-term shoulder health for young athletes.

3 Dec 2024

Natural proteins may offer new way to treat covid-19 and autoimmune disorders

Some people naturally have higher levels of proteins that protect them from covid-19. New studies at Umeå University of our immune system may pave the way for more personalized treatments of both covid-19 and autoimmune disorders.

2 Dec 2024

Who gets obesity drugs covered by insurance? In North Carolina, it helps if you’re on Medicaid

After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don't work.

2 Dec 2024

Tirzepatide cuts diabetes risk by 90% in obese patients, study shows

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions.

26 Nov 2024

First 'blueprint' of human skeletal development offers new insights into bone formation

The first 'blueprint' of human skeletal development reveals how the skeleton forms, shedding light on the process of arthritis, and highlighting cells involved in conditions that affect skull and bone growth.

21 Nov 2024

Electrical stimulation of vagus nerve could combat inflammatory bowel disease

Researchers at Duke University School of Medicine have found that tapping into the nervous system could help reduce the gut inflammation that drives inflammatory bowel disease (IBD).

20 Nov 2024

NSAIDs raise bleeding risk in patients taking blood thinners

People who take an anticoagulant medicine double their risk of an internal bleed if they take a type of painkiller called a non-steroidal anti-inflammatory drug (NSAID) such as ibuprofen, diclofenac or naproxen, according to research published in the European Heart Journal [1] today (Monday).

18 Nov 2024

New clinical trial offers hope for patients with rare immune disease IgG4-RD

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4-RD)

18 Nov 2024

Obesity crisis in the U.S. expected to worsen by 2050

Over the past three decades, there has been a startling increase in the prevalence of obesity across the USA, at least doubling in adult men and women (aged 25 and older) and older female and male adolescents (aged 15-24 years) since 1990, with the number of people living with overweight and obesity reaching over 208 million in 2021 - a trend set to continue in the coming decades without significant reform, according to a major new analysis from the Global Burden of Disease Study Collaborator Network, published in The Lancet.

15 Nov 2024

Phase 3 study finds inebilizumab effective for immunoglobulin G4–related disease

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

14 Nov 2024

Gut microbiome changes linked to onset of rheumatoid arthritis among at-risk individuals

Findings indicate gut microbiome diversity changes precede rheumatoid arthritis, offering insights into microbial indicators for early disease detection.

11 Nov 2024

MD Anderson launches new institute for advancing cell therapy

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and research expertise to lead the world in developing and advancing impactful cell therapies for patients in need.

8 Nov 2024

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

A reduction in BMI among adults is associated with lower health care spending, study suggests

Chikungunya's health and economic impact likely underestimated

Women with infertility have higher risk of developing systemic autoimmune diseases

Common farming pesticides linked to rheumatoid arthritis

Nanozyme breakthrough offers new hope for viral pneumonia treatment

UTHealth study could set new standards for treating acromioclavicular joint injuries in athletes

Natural proteins may offer new way to treat covid-19 and autoimmune disorders

Who gets obesity drugs covered by insurance? In North Carolina, it helps if you’re on Medicaid

Tirzepatide cuts diabetes risk by 90% in obese patients, study shows

First 'blueprint' of human skeletal development offers new insights into bone formation

Electrical stimulation of vagus nerve could combat inflammatory bowel disease

NSAIDs raise bleeding risk in patients taking blood thinners

New clinical trial offers hope for patients with rare immune disease IgG4-RD

Obesity crisis in the U.S. expected to worsen by 2050

Phase 3 study finds inebilizumab effective for immunoglobulin G4–related disease

Gut microbiome changes linked to onset of rheumatoid arthritis among at-risk individuals

MD Anderson launches new institute for advancing cell therapy

Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders

Gut bacteria changes may foreshadow rheumatoid arthritis

California expanded Medi-Cal to unauthorized residents. The results are mixed.

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in